BEST IPOSinopharm Group HK$10 billion (US$1.3 billion) IPOBookrunners: CICC; Morgan Stanley; UBS
After a sluggish start to the year, a number of prominent initial public offerings (IPOs) were conducted during 2009. Two in particular stand out: Sinopharm’s Hong Kong listing and Maxis’ re-listing on the Bursa Malaysia.
The rest of this content is available to subscribers and active trials only
Contact Jeremy Masters to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please call Jeremy Masters on +44 (0)20 7779 8036 or email email@example.com to discuss your requirements.